- 2014
- Press releases - 18.03.2014
Inserm is celebrating its 50th anniversary
To mark its 50th anniversary, Inserm has decided to deliver its key messages at around a hundred events which will take place all over France and involve all its staff, partners and supervisory bodies throughout the year.
- What's on? - 17.03.2014
Atmospheric pollution : what are the impacts on health?
For the last few days, several French cities have had to face episodes of air pollution by particulates, frequently exceeding alert threshold levels. Further information – On the Impact of air pollution on our health: Press release, “Large European study finds exposure to even low levels of air pollution during pregnancy increases risk of lower […]
- What's on? - 12.03.2014
Lack of efficacy of nicotine replacement patches in pregnant smokers
A national trial coordinated by Dr Ivan Berlin at La Pitié-Salpêtrière Hospital (AP-HP) and researchers from Inserm shows that nicotine replacement patches are not effective in helping pregnant women to stop smoking during their pregnancy. This work has been published in the British Medical Journal See the press release for further information (French version)
- Press releases - 11.03.2014
Non-coding genomic regions ameliorate the severity of beta-thalassemia and sickle cell anemia
Des régions non codantes du génome semblent diminuer la sévérité de deux maladies des globules rouges : la bêta thalassémie et la drépanocytose
- Press releases - 11.03.2014
How does light affect our brain’s performance?
Who would have thought that our brains are better equipped to process cognitive tasks if we are exposed to light several hours beforehand
- What's on? - 05.03.2014
Semaine du cerveau (Brain awareness week) 10-16 march 2014
The 15th edition of Brain Awareness Week will take place in France and in 62 countries around the world from 10 to 16 March 2014. Throughout this week, the general public will be able to meet researchers from Inserm to gain better knowledge of the brain and become better informed about recent research in this […]
- Press releases - 03.03.2014
Europe is joining forces against neglected parasitic diseases
The international consortium A-PARADDISE (Anti-Parasitic Drug Discovery in Epigenetics), coordinated by Inserm, has just obtained funds of €6 million from the European Commission to conduct large-scale testing of innovative therapies against four neglected parasitic diseases: schistosomiasis, leishmaniasis, Chagas disease and malaria.
- What's on? - 25.02.2014
Development of a bioartificial pancreas
European consortium BIOSID have developed a bioartificial pancreas that can directly produce insulin in the bodies of patients with type 1 diabetes, which should be tested in humans by 2015. Trials will be conducted by the team led by Eric Renard, a researcher at Inserm Unit 661, “Institute for Functional Genomics,” at Montpellier University Hospital, […]
- Press releases - 20.02.2014
Enhancement of chemotherapy by prevention of tumour cell repair
A team of researchers directed by Frédéric Coin, Inserm Research Director at the Institute of Genetics and Molecular and Cellular Biology (IGBMC) in Strasbourg (a Joint Inserm/CNRS/University of Strasbourg Research Unit), has discovered a new drug that inhibits repair: spironolactone, which seems likely to be used in the very short term as an adjuvant to chemotherapy.
- News in brief - 20.02.2014
Identification of the neuronal network that controls our actions and errors
When we perform an action for a specific purpose, or in response to a stimulus, it is imperative that we be able to correct it while carrying it out if it turns out to be inappropriate. Such an ability affects the quality of our daily lives, both in our immediate motor activity (not “running” a […]